These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16035223)

  • 1. Procedure for the quantitative evaluation of motor disturbances in cerebellar ataxic patients.
    Ferrarin M; Gironi M; Mendozzi L; Nemni R; Mazzoleni P; Rabuffetti M
    Med Biol Eng Comput; 2005 May; 43(3):349-56. PubMed ID: 16035223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive scheme for the objective upper body assessments of subjects with cerebellar ataxia.
    Tran H; Nguyen KD; Pathirana PN; Horne MK; Power L; Szmulewicz DJ
    J Neuroeng Rehabil; 2020 Dec; 17(1):162. PubMed ID: 33276783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of the International Cooperative Ataxia Scale rating in multiple system atrophy.
    Tison F; Yekhlef F; Balestre E; Chrysostome V; Quinn N; Wenning GK; Poewe W
    Mov Disord; 2002 Nov; 17(6):1248-54. PubMed ID: 12465064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reliability of the Japanese version of the Scale for the Assessment and Rating of Ataxia (SARA)].
    Sato K; Yabe I; Soma H; Yasui K; Ito M; Shimohata T; Onodera O; Nakashima K; Sobue G; Nishizawa M; Sasaki H
    Brain Nerve; 2009 May; 61(5):591-5. PubMed ID: 19514520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphomannomutase deficiency (PMM2-CDG): ataxia and cerebellar assessment.
    Serrano M; de Diego V; Muchart J; Cuadras D; Felipe A; Macaya A; Velázquez R; Poo MP; Fons C; O'Callaghan MM; García-Cazorla A; Boix C; Robles B; Carratalá F; Girós M; Briones P; Gort L; Artuch R; Pérez-Cerdá C; Jaeken J; Pérez B; Pérez-Dueñas B
    Orphanet J Rare Dis; 2015 Oct; 10():138. PubMed ID: 26502900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology.
    Trouillas P; Takayanagi T; Hallett M; Currier RD; Subramony SH; Wessel K; Bryer A; Diener HC; Massaquoi S; Gomez CM; Coutinho P; Ben Hamida M; Campanella G; Filla A; Schut L; Timann D; Honnorat J; Nighoghossian N; Manyam B
    J Neurol Sci; 1997 Feb; 145(2):205-11. PubMed ID: 9094050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment and Rating of Motor Cerebellar Ataxias With the Kinect v2 Depth Sensor: Extending Our Appraisal.
    Honda T; Mitoma H; Yoshida H; Bando K; Terashi H; Taguchi T; Miyata Y; Kumada S; Hanakawa T; Aizawa H; Yano S; Kondo T; Mizusawa H; Manto M; Kakei S
    Front Neurol; 2020; 11():179. PubMed ID: 32218767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of the Scale for Assessment and Rating of Ataxia (SARA).
    Yabe I; Matsushima M; Soma H; Basri R; Sasaki H
    J Neurol Sci; 2008 Mar; 266(1-2):164-6. PubMed ID: 17950753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of cerebellar ataxia in chronic alcoholics using the International Cooperative Ataxia Rating Scale (ICARS).
    Fitzpatrick LE; Jackson M; Crowe SF
    Alcohol Clin Exp Res; 2012 Nov; 36(11):1942-51. PubMed ID: 22568470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion tensor imaging of the cortico-ponto-cerebellar pathway in patients with adult-onset ataxic neurodegenerative disease.
    Kitamura K; Nakayama K; Kosaka S; Yamada E; Shimada H; Miki T; Inoue Y
    Neuroradiology; 2008 Apr; 50(4):285-92. PubMed ID: 18172629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring ataxia: quantification based on the standard neurological examination.
    Notermans NC; van Dijk GW; van der Graaf Y; van Gijn J; Wokke JH
    J Neurol Neurosurg Psychiatry; 1994 Jan; 57(1):22-6. PubMed ID: 8301300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive and quantitative evaluation of movement disorder disability using an infrared depth sensor.
    Tsukagoshi S; Furuta M; Hirayanagi K; Furuta N; Nakazato S; Fujii M; Yuminaka Y; Ikeda Y
    J Clin Neurosci; 2020 Jan; 71():135-140. PubMed ID: 31501004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of Handwriting of People With Cerebellar Ataxia: Three-Dimensional Movement Analysis of the Pen Tip, Finger, and Wrist.
    Fujisawa Y; Okajima Y
    Phys Ther; 2015 Nov; 95(11):1547-58. PubMed ID: 25953596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative assessment of cerebellar ataxia, through automated limb functional tests.
    Krishna R; Pathirana PN; Horne M; Power L; Szmulewicz DJ
    J Neuroeng Rehabil; 2019 Feb; 16(1):31. PubMed ID: 30813963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial.
    Ristori G; Romano S; Visconti A; Cannoni S; Spadaro M; Frontali M; Pontieri FE; Vanacore N; Salvetti M
    Neurology; 2010 Mar; 74(10):839-45. PubMed ID: 20211908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local Stability of the Trunk in Patients with Degenerative Cerebellar Ataxia During Walking.
    Chini G; Ranavolo A; Draicchio F; Casali C; Conte C; Martino G; Leonardi L; Padua L; Coppola G; Pierelli F; Serrao M
    Cerebellum; 2017 Feb; 16(1):26-33. PubMed ID: 26811155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative evaluation of functional limitation of upper limb movements in subjects affected by ataxia.
    Menegoni F; Milano E; Trotti C; Galli M; Bigoni M; Baudo S; Mauro A
    Eur J Neurol; 2009 Feb; 16(2):232-9. PubMed ID: 19146643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the oral form of ondansetron on cerebellar dysfunction. A multi-center double-blind study.
    Bier JC; Dethy S; Hildebrand J; Jacquy J; Manto M; Martin JJ; Seeldrayers P
    J Neurol; 2003 Jun; 250(6):693-7. PubMed ID: 12796831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychometric Properties of a Core Set of Measures of Balance for People With Cerebellar Ataxia Secondary to Multiple Sclerosis.
    Winser S; Smith CM; Hale LA; Claydon LS; Whitney SL; Klatt B; Mottershead J; Zaydan I; Heyman R
    Arch Phys Med Rehabil; 2017 Feb; 98(2):270-276. PubMed ID: 27577181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability and validity of ICARS in focal cerebellar lesions.
    Schoch B; Regel JP; Frings M; Gerwig M; Maschke M; Neuhäuser M; Timmann D
    Mov Disord; 2007 Nov; 22(15):2162-9. PubMed ID: 17712842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.